Cue Biopharma, Inc. (CUE) Shareholder Equity
- 2026-06-30: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $5.00K; Additional Paid in Capital, Common StockUSD $529.02M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD (m).
- 2026-03-31: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $3.00K; Additional Paid in Capital, Common StockUSD $395.25M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD (m).
- 2025-12-31: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $3.00K; Additional Paid in Capital, Common StockUSD $394.89M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD (m).
- 2025-09-30: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $78.00K; Additional Paid in Capital, Common StockUSD $383.22M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $1.00K.
Cue Biopharma, Inc. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Preferred Stock, Value, Issued USD | Common Stock, Value, Issued USD | Additional Paid in Capital, Common Stock USD | Accumulated Other Comprehensive Income (Loss), Net of Tax USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD | Adjustments to Additional Paid in Capital, Warrant Issued USD |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 | $5.00K | $529.02M | (m) | $-526.71M | $2.31M | 3 month · $23.84M 6 month · $23.89M | (m) | (m) |
| 2026-03-31 | $0.00 | $3.00K | $395.25M | (m) | $-373.64M | $21.61M | 3 month · $48.00K | (m) | (m) |
| 2025-12-31 | $0.00 | $3.00K | $394.89M | (m) | $-368.47M | $26.43M | 12 month · $4.74M | (m) | (m) |
| 2025-09-30 | $0.00 | $78.00K | $383.22M | $1.00K | $-370.05M | $13.25M | 3 month · $1.53M 9 month · $4.13M | (m) | (m) |
| 2025-06-30 | $0.00 | $76.00K | $380.69M | (m) | $-362.60M | $18.16M | 3 month · $1.26M 6 month · $2.60M | (m) | (m) |
| 2025-03-31 | $0.00 | $62.00K | $360.64M | (m) | $-354.12M | $6.58M | 3 month · $1.34M | (m) | (m) |
| 2024-12-31 | $0.00 | $62.00K | $359.30M | $0.00 | $-341.86M | $17.50M | 12 month · $6.85M | (m) | (m) |
| 2024-09-30 | $0.00 | $60.00K | $357.67M | (m) | $-332.37M | $25.37M | 3 month · $1.58M 9 month · $5.28M | (m) | (m) |
| 2024-06-30 | $0.00 | $48.00K | $345.28M | (m) | $-323.71M | $21.62M | 3 month · $1.75M 6 month · $3.70M | (m) | (m) |
| 2024-03-31 | $0.00 | $48.00K | $343.53M | (m) | $-313.54M | $30.04M | 3 month · $1.95M | (m) | (m) |
| 2023-12-31 | $0.00 | $47.00K | $338.23M | $0.00 | $-301.19M | $37.09M | 12 month · $8.18M | (m) | (m) |
| 2023-09-30 | $0.00 | $45.00K | $330.38M | $0.00 | $-287.75M | $42.67M | 3 month · $2.07M 9 month · $6.11M | (m) | (m) |
| 2023-06-30 | $0.00 | $44.00K | $322.71M | $-5.00K | $-276.75M | $46.00M | 3 month · $2.04M 6 month · $4.04M | (m) | (m) |
| 2023-03-31 | $0.00 | $43.00K | $318.58M | $-39.00K | $-263.56M | $55.02M | 3 month · $2.00M | (m) | (m) |
| 2022-12-31 | $0.00 | $43.00K | $316.19M | $-96.00K | $-250.46M | $65.68M | 12 month · $9.50M | (m) | (m) |
| 2022-09-30 | $0.00 | $35.00K | $286.69M | $-92.00K | $-235.86M | $50.76M | 3 month · $2.06M 9 month · $7.38M | (m) | (m) |
| 2022-06-30 | $0.00 | $35.00K | $284.63M | (m) | $-224.91M | $59.76M | 3 month · $2.31M 6 month · $5.32M | (m) | (m) |
| 2022-03-31 | $0.00 | $34.00K | $276.34M | $0.00 | $-211.70M | $64.67M | 3 month · $3.01M | (m) | (m) |
| 2021-12-31 | $0.00 | $32.20K | $262.91M | $0.00 | $-197.45M | $65.49M | 12 month · $11.52M | (m) | (m) |
| 2021-09-30 | (m) | $32.00K | $252.55M | (m) | $-189.06M | $63.52M | 3 month · $3.25M 9 month · $8.54M | (m) | (m) |
| 2021-06-30 | (m) | $31.00K | $248.95M | (m) | $-176.07M | $72.91M | 3 month · $2.85M 6 month · $5.29M | (m) | (m) |
| 2021-03-31 | (m) | $31.00K | $235.43M | (m) | $-165.79M | $69.67M | 3 month · $2.44M | (m) | (m) |
| 2020-12-31 | $0.00 | $30.35K | $232.16M | $7.13K | $-153.29M | $78.91M | 12 month · $10.48M | (m) | (m) |
| 2020-09-30 | (m) | $30.00K | $229.63M | $72.00K | $-142.18M | $87.55M | 3 month · $2.50M 9 month · $8.20M | (m) | (m) |
| 2020-06-30 | (m) | $29.00K | $212.12M | $155.00K | $-132.15M | $80.15M | 3 month · $2.52M 6 month · $5.70M | (m) | (m) |
| 2020-03-31 | (m) | $27.00K | $166.28M | $249.00K | $-121.32M | $45.24M | 3 month · $3.17M | (m) | (m) |
| 2019-12-31 | (m) | $26.56K | $163.07M | $-10.32K | $-108.50M | $54.58M | 12 month · $6.52M | (m) | (m) |
| 2019-09-30 | (m) | $23.00K | $126.58M | (m) | $-99.58M | $27.02M | 3 month · $1.44M 3 month · $1.44M 9 month · $4.53M | (m) | (m) |
| 2019-07-01 | (m) | (m) | (m) | (m) | (m) | $20.28M | (m) | (m) | (m) |
| 2019-06-30 | (m) | $21.00K | $112.85M | (m) | $-92.59M | $20.28M | 3 month · $1.32M 3 month · $1.32M 6 month · $3.08M | (m) | (m) |
| 2019-04-01 | (m) | (m) | (m) | (m) | (m) | $24.74M | (m) | (m) | (m) |
| 2019-03-31 | (m) | $21.00K | $107.79M | $-3.00K | $-83.07M | $24.74M | 3 month · $1.77M | (m) | (m) |
| 2018-12-31 | (m) | $20.70K | $105.76M | $-10.96K | $-71.80M | $33.97M | 12 month · $7.17M 24 month · $2.77M | 24 month · $8.40M | 24 month · $1.00K |
| 2018-09-30 | (m) | $20.00K | $99.58M | $-20.00K | $-60.18M | $39.40M | 3 month · $2.74M 9 month · $5.16M | (m) | (m) |
| 2018-07-01 | (m) | (m) | (m) | (m) | (m) | $49.23M | (m) | (m) | (m) |
| 2018-06-30 | (m) | $20.00K | $96.84M | (m) | $-47.63M | $49.23M | 3 month · $1.27M 6 month · $2.43M | (m) | (m) |
| 2018-04-01 | (m) | (m) | (m) | (m) | (m) | $55.26M | (m) | (m) | (m) |
| 2018-03-31 | (m) | $20.00K | $95.57M | (m) | $-40.34M | $55.24M | 3 month · $1.16M | (m) | (m) |
| 2017-12-31 | (m) | $19.46K | $94.41M | (m) | $-32.82M | $61.61M | 12 month · $2.78M | (m) | 12 month · $1.00K |
| 2016-12-31 | (m) | (m) | (m) | (m) | (m) | $15.18M | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Akebia Therapeutics, Inc. (AKBA) | United States | $0.255B | -10.35 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |